About Chamelio
Introduction
Chamelio is a New York-based legal intelligence platform, founded in 2024 by former in-house counsel and AI specialists, built specifically for in-house legal departments drowning in contracts, approvals, and fragmented institutional knowledge. Rather than another point solution, Chamelio positions itself as an AI "system of record" that connects legal data, workflows, and decision-making across the contract lifecycle — drafting, negotiation, signing, and post-execution operations. The company raised a $10 million seed round in January 2026 (on top of an earlier $5.7 million round led by Work-Bench) and serves around 100 customers, including Wiz, Socure, Lightricks, Global-e, Cellebrite, and Fiverr.
Contract Analysis
Chamelio turns unstructured legal content — contracts, templates, policies, and past negotiation history — into structured, searchable intelligence, combining AI redlining with obligation tracking and repository intelligence so legal teams can quickly find how a similar clause or deal was handled before.
Document Drafting
The platform supports AI-assisted redlining and drafting informed by a company's own templates and negotiation precedent, with agentic workflows intended to automate repetitive contract lifecycle steps while keeping governance and final sign-off with the legal team.
Pricing
Chamelio does not publish pricing publicly; as an early-stage, enterprise-focused seed-stage company, pricing is set per customer through direct sales conversations.
User Reviews and Ratings
As a company that only raised its seed round in January 2026, Chamelio does not yet have a meaningful public review base on sites like G2 or Capterra. Early signal comes primarily from investor commentary and its roughly 100-customer base of fast-growing technology companies rather than large-sample independent review data.
Verdict
Chamelio is worth watching for in-house legal teams at fast-growing tech companies who want a unified contract and knowledge layer rather than a patchwork of point tools, but as a seed-stage company it carries the usual early-stage risk profile and lacks the long review/track record of more established CLM vendors.